Back to top

Portola Pharmaceuticals, Inc. (PTLA) in Focus Stock Up 5.72%
June 18, 2014

Read MoreHide Full Article

Portola Pharmaceuticals, Inc. (PTLA - Free Report) was a big mover last session, as the company saw its shares gain nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 40.87% in the past one-month time frame.

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, yesterday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Portola Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Other attractive players in the healthcare industry include Illumina Inc. (ILMN - Free Report) carrying a Zacks Rank #1 (Strong Buy) along with Ariad Pharmaceuticals Inc. and Aeolus Pharmaceuticals Inc. , which carry the same rank as Portola Pharmaceuticals.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Portola Pharmaceuticals, Inc. (PTLA) - free report >>

Illumina, Inc. (ILMN) - free report >>


More from Zacks Tale of the Tape

You May Like